Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Marquette National Corporation (MNAT)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
29.000.00 (0.00%)
At close: 12:57PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close29.00
Open29.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range29.00 - 29.00
52 Week Range27.50 - 43.20
Volume9,403
Avg. Volume590
Market Cap125.547M
Beta (5Y Monthly)N/A
PE Ratio (TTM)13.43
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield1.12 (3.86%)
Ex-Dividend DateSep 15, 2022
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for MNAT

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • MARQUETTE NATIONAL CORP
    Weekly Stock ListLast week was the busiest of the quarter for earnings, with many sharp stock-price moves following above- or below-consensus results or changes in guidance. Through July 26, Refinitiv noted that 133 S&P 500 companies had reported earnings, with 76% beating expectations, above the long-term average of 66%. The blended (actual for those reporting and consensus for those still to report) growth rate is 6.2%, near the 5.6% expectation and indicating the "beats" have not been robust. But the sour mood coming into the quarter is being greeted with relief that profit shortfalls and lowered guidance are not rampant. Our analysts always look for companies that boost outlooks during earnings season. Raising guidance can be a catalyst for strong returns in the quarters ahead. Here is an initial list of BUY-rated companies in Argus coverage with raised guidance or increased outlooks during the 2Q22 EPS reporting season.
    Rating
    Fair Value
    Economic Moat
    13 days agoArgus Research
View more
  • We're sorry we weren't able to find anything about this topic.

Advertisement
Advertisement